Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Suraj Kapa

Clinical Cardiac Electrophysiology Rochester, MN Medical Doctor

NPI 1811100118 CMS profile 414721

200 1St St Sw, Rochester, MN 55905

Open in the dashboard

General payments

$91,888

200 records reported · program years 2019–2025

Research payments

$3,200

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$114,075 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Suraj Kapa of Rochester, MN is reported in the CMS Open Payments database as having received $91,888 across 200 general payments and $3,200 in research payments paid to them. Separately, studies naming them as principal investigator received $114,075 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 87th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,471 46
2024 General $26,991 51
2023 General $794 12
2023 Research $3,200 1
2021 General $20,497 18
2020 General $10,984 26
2019 General $13,151 47

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Suraj Kapa
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Suraj Kapa were reported at $19,471. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Suraj Kapa Clinical Cardiac Electrophysiology median Middle half National median
2019 $13,151 $2,361 $585–$8,260 $163
2020 $10,984 $993 $247–$4,351 $114
2021 $20,497 $1,185 $326–$4,739 $132
2022 $0 $2,073 $554–$6,789 $149
2023 $794 $2,568 $759–$8,159 $160
2024 $26,991 $2,557 $703–$7,403 $164
2025 $19,471 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $42,349 93 payments
  2. Abbott Laboratories $16,437 51 payments
  3. Biosense Webster, Inc. $14,544 31 payments
  4. Philips Electronics North America Corporation $11,342 5 payments
  5. BioSig Technologies, Inc. $3,188 7 payments
  6. Pfizer Inc. $3,150 1 payment
  7. Medtronic, Inc. $714 10 payments
  8. iRhythm Technologies, Inc. $94 1 payment
  9. Biotronik Inc. $70 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $54,287 15 payments
  2. Travel and Lodging $13,998 53 payments
  3. Food and Beverage $10,343 121 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,363 4 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $2,494 4 payments
  6. Grant $2,333 2 payments
  7. Education $70 1 payment
Products named General payments · program years 2019–2025
  1. Carto 3 $13,498 22 payments
  2. (8334) IGT_D Peripheral $10,750 3 payments
  3. General - Therapies General - Therapies_CRM $6,875 1 payment
  4. RHYTHMIA $6,306 27 payments
  5. General Therapies $5,974 3 payments
  6. ENSITE $4,803 5 payments
  7. TACTICATH ABLATION CATHETER, SENSOR ENABLED $4,513 12 payments
  8. VYNDAQEL $3,150 1 payment
  9. General - Therapies Therapies $2,872 5 payments
  10. FARAPULSE $2,713 11 payments
  11. Other $20,639 92 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Pfizer Inc. $3,200 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

136

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$56,675

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

50%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 51 $51,141
Dofetilide Generic 12 $4,839
Amiodarone Hcl Generic 30 $341
Metoprolol Succinate Generic 26 $318
Metformin Hcl Er Metformin Hcl Brand 17 $37

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 50 billing codes

Paid by Medicare

$143,725

Medicare's payments for the services billed

Medicare patients

1,131

Average age 77

Services billed

2,176

395 women, 736 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 68%
Heart failure 64%
Ischemic heart disease 53%
Chronic kidney disease 48%
Arthritis 41%
Diabetes 31%
Cancer 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

201 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record